Name: TSM12+IP6

Alias: TSM12 Immune Peptide + Inositol Hexaphosphate Composite Anti-Cancer & Immune Blend CAS Registry number: N/A (Two-component compound mixture) Sequence: TSM12 polypeptide complex + IP6 CAS: 83-86-3 Molecular Formula: IP6: C?H??O??P? Molecular Weight: IP6: 660.04 Da Purity: TSM12 ≥99%, IP6 ≥99% (by HPLC) Appearance: White lyophilized mixed powder Packing: 10mg*10vials/box Product Group: Immune cell activation, antioxidant & abnormal cell proliferation inhibition composite blend

Storage Conditions: Store at -20℃ in a dry, dark place; avoid repeated freeze-thaw cycles.

Brief Introduction:

TSM12+IP6 is a dual-component composite blend combining immune-regulating TSM12 peptide and IP6 phytic acid, exclusively for laboratory research. TSM12 activates tumor-killing immune cell proliferation and cytokine secretion, strengthens innate anti-abnormal-cell immune response; IP6 inhibits abnormal cell proliferation signaling, chelates oxidative metal ions to reduce intracellular ROS damage, suppresses chronic inflammatory microenvironment conducive to lesion progression. The two ingredients exert synergistic effects on immune surveillance, free radical clearance and abnormal cell growth inhibition. Widely applied in tumor immunology, immune cell activation, antioxidant metal chelation and abnormal cell proliferation intervention laboratory studies.

Main Research Applications:

Tumor immune surveillance research: Study TSM12-mediated killer immune cell activation and cytokine secretion mechanisms. IP6 anti-proliferation research: Explore abnormal cell growth signal suppression and metal ion chelation antioxidant pathways. Synergistic immune anti-lesion research: Investigate dual-component combined immune regulation and proliferation inhibition effects. Chronic inflammation microenvironment research: Analyze persistent inflammatory lesion progression suppression.

Composite immune anti-proliferation blend research: Research TSM12+IP6 dual-component synergistic advantages.